1 completed, 1 withdrawn. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Withdrawn 1 |
| Phase 2 | 1 | Completed 1 |
Follow ZMapp: new trials by email Literature Review of ZMapp trials Research Report on ZMapp
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Putative Investigational Therapeutics in the Treatment of Patients With Known Ebola Infection B/Current Standard of Care Plus ZMapp, A/Current Standard of Care Alone - Ebola Virus Infection | Phase 1 / Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 72 | 2015-03-13 | 2019-06-05 |
| Safety and Pharmacokinetics of a Single ZMappTM Administration in Healthy Adult Volunteers ZMAPP - Healthy | Phase 1 | Withdrawn | National Institute of Allergy and Infectious Diseases (NIAID) | 2015-03-11 | 2019-12-16 |
National Institute of Allergy and Infectious Diseases (NIAID) (2)
Guinea (1) · Liberia (1) · Sierra Leone (1) · United States (1)